"The Venture Capital Day of Shenzhen" Shenzhen Angel FOF Industry High Quality Development Conference Successfully Concluded"
On April 8, 2024, the "The Venture Capital Day of Shenzhen" and Shenzhen Angel FOF Industry High Quality Development Conference concluded successfully in Futian District, Shenzhen. Co-organized by the Office of the Finance Committee of the CPC Shenzhen Municipal Committee, the Office of the Science and Technology Innovation Committee of the CPC Shenzhen Municipal Committee, and the Shenzhen Bureau of Industry and Information Technology, the event aims to gather global VC resources, explore innovative cooperation models, accelerate the cultivation of new productivity, and promote high-quality development of the industry.
(Seed Funding Eco-Cooperative Investment Discourse - Roundtable)
With the theme of "Angel Leads, Industry Escorts", this Venture Capital Conference invited four industry leaders to give keynote speeches on "Playing the Role of Angels, Accelerating the Cultivation of New Productivity", "Innovation Breakthroughs in China's Cardio-Cerebral Vascular Medical Device Industry", "Deconstructing Industrial Investment in the Context of Central Enterprises", "Open Innovation Practice in China", and "China's Experience of Open Innovation" as follows.
1. Accelerating the Cultivation of New Productivity through the Role of "Angels".
This topic focuses on the role of angel investment, and discusses how to accelerate the cultivation and development of new productivity through the support of angel investors. This is an important topic focusing on innovation and entrepreneurship, aiming to inspire more entrepreneurs to innovate.
2. Innovative Breakthroughs in China's Cardiovascular Medical Device Industry.
This feature focuses on the innovative development of the cardiovascular medical device industry, exploring breakthroughs and future trends in the field. As medical technology continues to advance, innovation in the cardiovascular and cerebrovascular field is of great significance to human health, and this special report provides new ideas and impetus for the development of the industry.
3. Deconstructing Industrial Investment in the Context of Centralized Enterprises.
This topic focuses on the role and influence of centralized enterprises in the field of industrial investment, and analyzes the characteristics, challenges and opportunities of centralized enterprises' investment. As an important part of the national economy, central enterprises play an important role in industrial investment; deconstructing industrial investment in the context of central enterprises helps to better understand the direction and trend of the country's economic development.
4. Chinese Practices of Open Innovation.
This panel discusses China's practical experiences and achievements in open innovation. Open innovation is the process of realizing innovation by sharing knowledge and resources with external partners. As a key player in the global economy, China's practical experience in open innovation is of great significance in promoting global innovation cooperation.
These topics cover a number of key issues in the field of venture capital, from angel investment to industrial innovation, showing the profound insights and forward-looking thinking of leading industry experts from all parties on the development of the industry, and providing important ideas and directions for promoting the high-quality development of the industry.
(Speech by Mr. Xu Xiangdong, Deputy General Manager of Shenzhen Angel Investment Guiding Fund Management Co.)
(Speech by Liu Heng, Deputy General Manager of the National Innovation Center for Adavanced Medical Devices)
Focusing on high-end medical devices, the conference's high-end medical devices session invited relevant industry experts Dr. Wang Chun'an, Director of the Institute of Biological Economy, Innovation Center of Shenzhen Development and Reform Commission, and Dr. Chen Zhenlang, LINKS Medical Scientific (Shanghai) Co., Ltd. to conduct keynote sharing, and arranged 8 high-quality projects to conduct roadshows. This event aims to build a capital bridge, realize the effective empowerment of financial water to scientific and technological innovation, help promote the innovative development of high-end medical device industry by scientific and technological innovation, and accelerate the cultivation of new quality productivity.
Mr. Xu Xiangdong, Deputy General Manager of Shenzhen Angel Investment Guiding Fund Management Co., Ltd, expressed his expectation and outlook on the high-quality development of the industry in his opening speech. Liu Heng, Deputy General Manager of the National Innovation Center for High Performance Medical Devices, the organizer of this session, was also present to deliver an important speech at the meeting.
(Wang Chun'an, Director, Institute of Bioeconomy, Innovation Center, Shenzhen Development and Reform Commission)
Dr. Wang Chunan, Director of the Institute of Biological Economy, Innovation Center of Shenzhen Development and Reform Commission, shared his views and experiences on the current development status and policies of Shenzhen's high-end medical device industry cluster. He pointed out that Shenzhen, as an important base of domestic medical device industry, has a good industrial foundation and international competitiveness, and will focus on promoting industrial integration, optimizing registration and declaration, and innovative talent subsidies in the future.
(Report on "Innovative Devices Going Overseas in the EU" - Dr. Chen Zhenlang, Founder of LinksCRO)
In addition, Dr. Chen Zhenlang, the founder of LINKS Medical Scientific (Shanghai) Co., Ltd. , also drew great attention with his keynote speech, "Innovative Medical Devices Going Overseas in the European Union: FromA Clinical Perspective". In view of the current difficulties faced by innovative medical devices, Dr. Chen elaborated on "why go to sea, how to go to sea, and whether to go to sea after all" and put forward suggestions and strategies on how to develop overseas markets smoothly.
(Dr. Han Long, General Manager of Softstar Technology, introduces the new generation of surgical robots project.)
(Mr. Dai Xi Huang, Director of Financing of Maibu Robotics, introduced the intelligent robot project for rehabilitation and elderly care.)
In addition, eight entrepreneurs, including Dr. Han Long, General Manager of Softstar Technology, Mr. Dai Xihuang, Financing Director of Maibu Robotics, and Dr. Hu Nan of NCC, also introduced the latest projects of their respective companies in the roadshow, which are dedicated to the domestic substitution and the solution of necklace technology, demonstrating the innovation vitality and development potential of the medical device industry.
By this conference, participants deeply appreciated Shenzhen's vitality and potential in the field of innovation and entrepreneurship, and contributed new ideas and strength to promote industrial upgrading and economic development.
LINKS CRO
As a CRO company providing clinical trial services. LINKS CRO focus on innovation, high-risk implantation(intervention) medical device, with one-stop clinical trial solutions for the whole process of medical device research and development.The headquarters of LINKS is based in Shanghai, with subsidiary branches in Beijing, Shanghai, Guangzhou, and Shenzhen, in addition to ten regional offices. The current workforce comprises almost 200 employees, with technical personnel making up over 85% and dispersed across almost 30 cities nationwide.
Key Services include CRO, SMO, CER, Audit, Post-market research, core laboratory registration both domestically and overseas, innovation declaration, Expert Consultancy, and overseas enterprise agency services.
Key Indications include Cardiovascular, Neurovascular, Peripheral Vascular, Surgery Robot, Oncology, Ophthalmology, Medical Cosmetology, and other fields such as orthopedics. There are almost 300 projects consultations and services by LINKS each year.
